Projecting the effectiveness of RotaTeq(®) against rotavirus-related hospitalizations and deaths in six Asian countries

RotaTeq is an oral pentavalent rotavirus vaccine (RV5) that has shown high and consistent efficacy in preventing rotavirus gastroenteritis (RGE) in randomized clinical trials conducted mostly in industrialized countries. We projected the effectiveness of RV5 against RGE-related hospitalizations and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: El Khoury, Antoine C, Mast, T Christopher, Ciarlet, Max, Markson, Leona E, Goveia, Michelle G
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2011
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166494/
https://ncbi.nlm.nih.gov/pubmed/21422820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.7.5.14620
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars